Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1

Interventions

Specimen Handling 2Paclitaxel 2binimetinib 1aldesleukin 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1MBT-0206 1Interleukin-2 1Genetic Counseling 1Gemcitabine 1Educational Status 1Early Intervention, Educational 1Biopsy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Triple Negative Breast Neoplasms × Methods × Clear all
NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

M.D. Anderson Cancer Center

Phase NA Suspended
5,200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡